Media

09 nov 2022

Startup a elevato impatto sociale: 19 società innovative italiane, EconomyUp

21 apr 2021

Biotech, l’occasione italiana, Corriere della Sera

12 apr 2021

BioInItaly Investment Forum di Assobiotec e Intesa Sanpaolo. Sei miliardi per coltivare le startup del biotech, Corriere Economia

12 apr 2021

BioInItaly Investment Forum 2021, quattro delle finaliste sono biotech e medical devices, About Pharma

27 jun 2020

Dai funghi ai microelettrodi. La carica delle 50 startup, Avvenire

22 jun 2020

Usiamo il virus HIV per curare col DNA le cellule malate, Il Giornale di Vicenza

02 apr 2020

Lettera aperta al Governo Italiano per sostenere le startup e PMI innovative, Corriere della Sera

feb 2020

Quando la cura siamo noi, BenEssere

17 jan 2020

Biotech, nascerà a San Francisco la casa delle start up italiane, Il Sole 24 Ore

11 jan 2020

Tutto pronto per la J.P.Morgan Healthcare di San Francisco: la più grande conferenza mondiale sul biotech, StartupItalia

08 jan 2020

Biotech italiano a San Francisco: Da Altheia a Wise, parte la missione delle start up alla conferenza mondiale JP Morgan, Corriere della Sera

11 jan 2023

Healthcare: Italy on the Move 2023

With the participation of Paolo Rizzardi, Chairman & CEO Altheia Science, to the panel “SME and start-ups in Italian Life Sciences Industry: growth, innovation, global partnerships”

Leaflet     More info

26 nov 2022

Nucleate Italian Chapter Launch

Presenting: Paolo Rizzardi, Chairman & CEO Altheia Science

10 may 2021

Giornata delle biotecnologie – streaming on Corriere.it

With the participation to the panel of Alessandra Biffi, Scientific Advisor and Founder Altheia Science
More info

8 apr 2021

StartUp Initiative / BioInItaly Investment Forum 2021 – the final

Presenting: Paolo Rizzardi, Chairman & CEO Altheia Science
Altheia Science receives the Gabriele Corbelli Award

15 jan 2020

Healthcare: Italy on the Move 2020

With the participation of Paolo Rizzardi, Chairman & CEO Altheia Science, to the panel “Why invest in Italian Life Sciences”.

More info

14 may 2019

Altheia Science Appoints Gaurav Shah to Board of Directors

19 dec 2018

Altheia Science Announced the Final Closing of the Series A Capital Raise Banking $19.3M (€17M), well above the initial target of $11.4M (€10M)

24 sep 2018

Bridging Boston to Milano, Altheia Science Banked the First $11M Over a Series A Capital Raise